Evidence map›Paper›PMID 23392966›Full record

ArticleJournal of materials science. Materials in medicine2013

In vitro and in vivo biocompatibility of apatite-coated magnetite nanoparticles for cancer therapy.

Elia Martha Múzquiz-Ramos, D A Cortés-Hernández, J C Escobedo-Bocardo, Alejandro Zugasti-Cruz, X S Ramírez-Gómez, J G Osuna-Alarcón

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Biocompatibility Evaluation of TiONanomaterials (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Elia Martha Múzquiz-RamosCINVESTAV IPN-Unidad Saltillo, Saltillo, Ramos Arizpe, COAH, Mexico. emuzquiz@uadec.edu.mx
D A Cortés-Hernández
J C Escobedo-Bocardo
Alejandro Zugasti-Cruz
X S Ramírez-Gómez
J G Osuna-Alarcón
Universidad Autónoma de Coahuila · MXInstituto Tecnológico de Saltillo · MXUniversidad de Guanajuato · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to determine the biocompatibility and potential toxicity of apatite-coated magnetite nanoparticles. The in vitro biocompatibility with human red blood cells was evaluated, not hemolytic effects were found at concentrations lower than 3 mg/ml. For the in vivo study, Balb/c mice were used. The animals were injected intravenously or intraperitoneally, the doses ranged from 100 to 2,500 mg/Kg. All the injected animals showed normal kidney and liver function. No significant changes were found in the body weight, the organs weight and the iron levels in liver due to the administration. In conclusion, apatite-coated magnetite nanoparticles did not induce any abnormal clinical signs in the laboratory animals. The results demonstrated that apatite-coated magnetite nanoparticles of 8 ± 2 nm in size did not have hemolytic effect in human erythrocytes and did not cause apparent toxicity in Balb/c mice under the experimental conditions of this study.

Indexed as

ApatitesBiocompatible MaterialsFerrosoferric OxideNanoparticlesAnimalsAntineoplastic AgentsFemaleHumansLethal Dose 50MaleMiceMice, Inbred BALB COrgan SizeAntineoplastic AgentsApatitesBiocompatible MaterialsFerrosoferric Oxide

Identifiers

PMID23392966
OpenAlexW2017246870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.